Skip to main navigation

Top Bar Nav

Contact Us

Social Icons

linkedin twitter

About Nav

About

Pioneering Pathways

Pioneering Pathways

Medicines Nav

Medicines

Science Nav

Science

Our Purpose Nav

Our Purpose

Our Stories

Our Stories

News Nav

News

IR Nav

Investors

Careers Nav

Careers

Home News Press Release Archive

Press Release Archive

News Nav

News
Press Release Archive
Events Archive
Our Stories

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Press Release Archive

Year

Jazz Pharmaceuticals and Codiak BioSciences Announce Strategic Collaboration to Research, Develop and Commercialize Engineered Exosomes to Create Therapies for Hard-to-Treat Cancers

January 3, 2019

Jazz Pharmaceuticals Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea

December 21, 2018

Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 7

December 19, 2018

Jazz Pharmaceuticals Announces Share Repurchase Program Authorization Increase of $400 Million

December 10, 2018

Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia

November 29, 2018

Jazz Pharmaceuticals to Highlight Hematology Research at ASH 2018 Annual Meeting

November 28, 2018

Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea

November 9, 2018

Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences

November 7, 2018

Jazz Pharmaceuticals Announces Third Quarter 2018 Financial Results

November 6, 2018

Jazz Pharmaceuticals Announces FDA Approval of Xyrem® (sodium oxybate) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients

October 29, 2018

Pagination

First page
Previous page
…
Page 21
Page 22
Page 23
Page 24
Current page 25
Page 26
Page 27
Page 28
Page 29
…
Next page
Last page

Displaying 241 - 250 of 559

About Nav

About

Pioneering Pathways Nav

Pioneering Pathways

Medicines Nav

Medicines

Science Nav

Science

Our Purpose Nav

Our Purpose

Our Stories Nav

Our Stories

News Nav

News

Careers Nav

Careers

IR Nav

Investors

© 2024 Jazz Pharmaceuticals plc All Rights Reserved.

Legal Nav

Privacy Statement
Terms of Use
Social Media Global Guidelines
Cookie Policy
Sitemap